Clinical Trial Update: Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for octohydroaminoacridine succinate tablets in Alzheimer's disease; no results or current trial status are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Octohydroaminoacridine Succinate Tablets (octohydroaminoacridine succinate)

Snippet

Sponsor: Changchun Huayang High-tech Co., Ltd | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN